TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19760309

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation followed by surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 17275158

Group type: EXPERIMENTAL
Intervention: Skillreporter manikin (continuous feedback)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional manikin (instructor feedback)
Number of subjects: 98
Study: 15184222

Group type: EXPERIMENTAL
Intervention: Academic detailing and parental education program
Number of subjects: 11

Group type: COMPARATOR
Intervention: Practice-specific report cards
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cephalosporins
Number of subjects: 11
Study: 11435293

Group type: EXPERIMENTAL
Intervention: Nonleukoreduced RBCs
Number of subjects: 93

Group type: COMPARATOR
Intervention: Leukoreduced RBCs
Number of subjects: 93
Study: 10396521

Group type: EXPERIMENTAL
Intervention: Interview administration of questionnaire
Number of subjects: 431

Group type: COMPARATOR
Intervention: Postal administration of questionnaire
Number of subjects: 431
Study: 8041988

Group type: EXPERIMENTAL
Intervention: Weekly chemotherapy with 7 active drugs (cyclophosphamide + adriamycin + etoposide on day 1; cisplatin + vindesine on day 8; methotrexate + vincristine on day 15)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Standard regimen (cyclophosphamide + adriamycin + etoposide given at the cycle beginning)
Number of subjects: 215
Study: 2011707

Group type: EXPERIMENTAL
Intervention: Rehydration of faecal occult blood tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-rehydration of faecal occult blood tests
Number of subjects: 0
Study: 6787557

Group type: EXPERIMENTAL
Intervention: Intermittent gastric gavage feedings
Number of subjects: 53

Group type: COMPARATOR
Intervention: Transpyloric (nasojejunal) feedings
Number of subjects: 53
Study: 30470465

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Regional Anesthesia (RA)
Number of subjects: 401
Study: 28392859

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional training group (CTG)
Number of subjects: 55
Study: 26866770

Group type: EXPERIMENTAL
Intervention: SMR neurofeedback training (SMR NFT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 23360662

Group type: EXPERIMENTAL
Intervention: escitalopram (ESC)+bupropion (BUP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: escitalopram (ESC)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: bupropion (BUP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: N1 sLORETA-LDAEP
Number of subjects: 51
Study: 21254797

Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 19616204

Group type: EXPERIMENTAL
Intervention: Inanimate simulator training (6 hours)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Virtual simulator training (4 hours with LapSim)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 17
Study: 17535634

Group type: EXPERIMENTAL
Intervention: SGD group (100 mg Tobramycin, 40 mg garlicin, and 20% Lactulose for 10 ml three times per day for 3 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (preoperative bowel preparation: diet preparation and enema)
Number of subjects: 30
Study: 15194029

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (no hyperbaric oxygen therapy)
Number of subjects: 61
Study: 11277584

Group type: EXPERIMENTAL
Intervention: Nociceptive nerve terminals in neuropathic patients
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Neuropathic patients
Number of subjects: 90
Study: 9797906

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (25 micrograms/day for 8 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (250 micrograms/day for 8 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (1250 micrograms/day for 8 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 25(OH)D3 (10 micrograms/day for 4 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 25(OH)D3 (20 micrograms/day for 4 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 25(OH)D3 (50 micrograms/day for 4 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3 (0.5 microgram/day for 2 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3 (1.0 microgram/day for 2 weeks)
Number of subjects: 116
Study: 8056008

Group type: EXPERIMENTAL
Intervention: Elgodipine 20 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Elgodipine 40 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Elgodipine 60 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3060024

Group type: EXPERIMENTAL
Intervention: Skin to skin contact (35 infants)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (36 infants)
Number of subjects: 71
Study: 31397129

Group type: EXPERIMENTAL
Intervention: Grain-moxibustion combined with medicine therapy (vitamin E capsules and Wuzi Yanzong pills)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (vitamin E capsules and Wuzi Yanzong pills)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Grain-moxibustion combined with medicine therapy
Number of subjects: 60
Study: 27940180

Group type: EXPERIMENTAL
Intervention: Lifestyle weight loss (LWL) intervention delivered by community health workers
Number of subjects: 260

Group type: COMPARATOR
Intervention: Diabetes self-management (DSM) education condition
Number of subjects: 260
Study: 25088520

Group type: EXPERIMENTAL
Intervention: structured dietary treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: physical exercise treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: combined treatment
Number of subjects: 68

Group type: COMPARATOR
Intervention: usual care (controls)
Number of subjects: 68
Study: 23562754

Group type: EXPERIMENTAL
Intervention: Hybrid therapy (40 mg omeprazole and 1 g amoxicillin, twice daily for 14 days; 500 mg clarithromycin and 500 mg nitroimidazole added, twice daily for the final 7 days)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Concomitant therapy (same 4 drugs taken concurrently, twice daily for 14 days)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Hybrid therapy
Number of subjects: 343

Group type: COMPARATOR
Intervention: Concomitant therapy
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 343
Study: 21840720

Group type: EXPERIMENTAL
Intervention: Modified techniques of Bryan cervical disc arthroplasty
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard techniques of Bryan cervical disc arthroplasty
Number of subjects: 49
Study: 17700582

Group type: EXPERIMENTAL
Intervention: NIHImage
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SliceOmatic
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Analyze
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HippoFat
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EasyVision
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fully automated program
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Semi-automated approaches
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: VAT measurements
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SAT and CSA measurements
Number of subjects: 15
Study: 16280230

Group type: EXPERIMENTAL
Intervention: Computerized Tests of Information Processing (CTIP) - includes Simple RT, Choice RT, and Semantic Search RT
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (cognitively‐intact individuals)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Mild TBI group
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Severe TBI group
Number of subjects: 4
Study: 15128184

Group type: EXPERIMENTAL
Intervention: Lactate stress test using Acutrend Lactate (LST2)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Lactate stress test using Ektachrome Clinical Chemistry Slide (LST1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Comparison of LST1 and LST2
Number of subjects: 63
Study: 11121928

Group type: EXPERIMENTAL
Intervention: CSEcure(R) (SIMS Portex, UK) locking needle
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional, non-locking technique
Number of subjects: 200
Study: 8639239

Group type: EXPERIMENTAL
Intervention: Resin-bonded fixed partial dentures with high noble alloy inlay retainers and a metal ceramic pontic (51 total dentures)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Tin-plated fixed partial dentures (14 total dentures)
Number of subjects: 39
Study: 1410160

Group type: EXPERIMENTAL
Intervention: High-nicotine cigarette
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ultralow-nicotine cigarette
Number of subjects: 22

Group type: COMPARATOR
Intervention: Medium-nicotine cigarette
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Plasma nicotine levels
Number of subjects: 22
Study: 3935377

Group type: EXPERIMENTAL
Intervention: 100 mg fluvoxamine as a single daytime dose
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 100 mg fluvoxamine as a single night-time dose
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 50 mg fluvoxamine twice daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (1 week wash-out period)
Number of subjects: 62
Study: 30148993

Group type: EXPERIMENTAL
Intervention: Suture pulley ESD
Number of subjects: 13

Group type: COMPARATOR
Intervention: Traditional ESD
Number of subjects: 13
Study: 29720146

Group type: EXPERIMENTAL
Intervention: Daily SMS reminders in addition to usual treatment
Number of subjects: 279

Group type: COMPARATOR
Intervention: Usual treatment only
Number of subjects: 279
Study: 27558186

Group type: EXPERIMENTAL
Intervention: Androstenedione (300 mg for 7 days)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Cellulose placebo (control)
Number of subjects: 11
Study: 24831252

Group type: EXPERIMENTAL
Intervention: Nasal mask
Number of subjects: 21

Group type: COMPARATOR
Intervention: Oronasal mask
Number of subjects: 21
Study: 22536983

Group type: EXPERIMENTAL
Intervention: Exercise training for 16 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 30
Study: 20602723

Group type: EXPERIMENTAL
Intervention: Chronic Migraine (CM)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Episodic Migraine (EM)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both CM and EM
Number of subjects: 300
Study: 17722965

Group type: EXPERIMENTAL
Intervention: Nitazoxanide
Number of subjects: 0
Study: 16220865

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 3204

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccination
Number of subjects: 3204

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 3204
Study: 12118965

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B
Number of subjects: 81

Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 81
Study: 9987544

Group type: EXPERIMENTAL
Intervention: Continuous cardiac output measurement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bolus cardiac output measurement
Number of subjects: 60
Study: 8560587

Group type: EXPERIMENTAL
Intervention: Albendazole (two different dosages)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not treated)
Number of subjects: 0
Study: 2125681

Group type: EXPERIMENTAL
Intervention: Alteplase (recombinant tissue-type plasminogen activator, t-PA)
Number of subjects: 12490

Group type: COMPARATOR
Intervention: Streptokinase (SK)
Number of subjects: 12490

Group type: COMPARATOR
Intervention: Streptokinase (SK) with heparin
Number of subjects: 12490

Group type: EXPERIMENTAL
Intervention: Alteplase (t-PA) with or without heparin
Number of subjects: 12490

Group type: EXPERIMENTAL
Intervention: Alteplase (t-PA)
Number of subjects: 12490
Study: 6108123

Group type: EXPERIMENTAL
Intervention: Temazepam 40 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30778546

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 6661

Group type: EXPERIMENTAL
Intervention: Combination of acupuncture and herbal medicine
Number of subjects: 6661
Study: 27416886

Group type: EXPERIMENTAL
Intervention: Hospital Readmissions Reduction Program (HRRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group of patients treated at hospitals with readmission rates below or equal to the national average (not at risk)
Number of subjects: 0
Study: 25870325

Group type: EXPERIMENTAL
Intervention: TDF/FTC
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 23467207

Group type: EXPERIMENTAL
Intervention: L-citrulline (100mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (Maltodextrin)
Number of subjects: 16
Study: 21502796

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg tid) with normo-caloric diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normo-caloric diet without orlistat
Number of subjects: 20
Study: 19156832

Group type: EXPERIMENTAL
Intervention: Autologous platelet adhesive
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no autologous platelet adhesive)
Number of subjects: 12
Study: 17870038

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg elemental calcium daily for 12 months)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Calcium supplementation and placebo
Number of subjects: 86
Study: 15370943

Group type: EXPERIMENTAL
Intervention: Sertraline (200 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 11078484

Group type: EXPERIMENTAL
Intervention: MCC-CRM(197)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: MCC-TT
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: MCC-CRM(197) and MCC-TT
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Polysaccharide booster
Number of subjects: 226
Study: 9681390

Group type: EXPERIMENTAL
Intervention: TNF‐alpha
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: sTNF‐R p55
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: sTNF‐R p75
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: TNF‐beta
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (14 healthy subjects)
Number of subjects: 66
Study: 7924480

Group type: EXPERIMENTAL
Intervention: Nocturnal nasal continuous positive airway pressure (CPAP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Matched controls (not specified)
Number of subjects: 8
Study: 2924091

Group type: EXPERIMENTAL
Intervention: High-resolution computed tomography (CT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional radiology
Number of subjects: 62
Study: 60988

Group type: EXPERIMENTAL
Intervention: RNAse
Number of subjects: 507

Group type: COMPARATOR
Intervention: gamma globulin
Number of subjects: 507
Study: 31988084

Group type: EXPERIMENTAL
Intervention: Opportunistic screening using a single-lead ECG device
Number of subjects: 17107

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 17107

Group type: EXPERIMENTAL
Intervention: Screened patients
Number of subjects: 17107

Group type: EXPERIMENTAL
Intervention: Patients with newly diagnosed AF in intervention practices
Number of subjects: 17107
Study: 31660823

Group type: EXPERIMENTAL
Intervention: Sodium benzoate (DAAO inhibitor), 2 g per day for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28745788

Group type: EXPERIMENTAL
Intervention: Continuous nursing
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (COPD health education at discharge)
Number of subjects: 106
Study: 25232809

Group type: EXPERIMENTAL
Intervention: Selenium (200 μg per day from L-selenomethionine)
Number of subjects: 11267

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU per day of all rac-α-tocopheryl acetate)
Number of subjects: 11267

Group type: COMPARATOR
Intervention: No selenium (control group)
Number of subjects: 11267

Group type: COMPARATOR
Intervention: Placebo (control group for vitamin E)
Number of subjects: 11267
Study: 23817144

Group type: EXPERIMENTAL
Intervention: Healing Touch with Music (HTM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention Control with Music (ACM)
Number of subjects: 0
Study: 21709297

Group type: EXPERIMENTAL
Intervention: AGE-restricted diet (<10 AGE Eq/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard diet (>20 AGE equivalents [Eq]/day)
Number of subjects: 36
Study: 19366132

Group type: EXPERIMENTAL
Intervention: Minimal incision technique
Number of subjects: 81

Group type: COMPARATOR
Intervention: Traditional incision technique
Number of subjects: 81
Study: 16369811

Group type: EXPERIMENTAL
Intervention: CEE + MPA (0.625 mg/day + 2.5 mg/day)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg/day)
Number of subjects: 58
Study: 12771456

Group type: EXPERIMENTAL
Intervention: GnRH analogues plus ultrasound-guided aspiration of endometriomas
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intracystic injection of recombinant interleukin-2 (rIL-2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no rIL-2)
Number of subjects: 24
Study: 11151733

Group type: EXPERIMENTAL
Intervention: Cordis Orbis Sigma valve
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medtronic PS Medical Delta valve
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard valve designs
Number of subjects: 0
Study: 9078538

Group type: EXPERIMENTAL
Intervention: Postoperative thyroid hormone levels after cardiac surgery
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Postoperative urinary iodine excretion
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Patients with postoperative T3 plasma concentrations less than 0.6 nmol/L
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Patients treated with dopamine
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Cumulative doses of inotropic and vasoactive catecholamines and furosemide
Number of subjects: 132
Study: 8337017

Group type: EXPERIMENTAL
Intervention: Counseling regarding specific management techniques
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Car-ride simulation device
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (reassurance and support)
Number of subjects: 38
Study: 3725653

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional therapy (ampicillin and chloramphenicol)
Number of subjects: 85
Study: 29798075

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin as bridge therapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no warfarin)
Number of subjects: 58
Study: 25656505

Group type: EXPERIMENTAL
Intervention: Cognitive intervention program (multidomain cognitive stimulation including art, music, recollection, and horticultural therapy, 1 hour each session, 5 times per week for 6 months)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cognitive intervention program
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (pharmacotherapy only)
Number of subjects: 53
Study: 25010104

Group type: EXPERIMENTAL
Intervention: Therapy sessions (6 weekly 1-hour sessions)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Therapeutic index (TI) measured using skin conductance resonance
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subjective measure of therapeutic alliance (Working Alliance Inventory)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall anxiety levels
Number of subjects: 30
Study: 22159005

Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment (4 times a day with subsequent reduction)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 110
Study: 20178588

Group type: EXPERIMENTAL
Intervention: General Practitioners' views on diagnosing CFS/ME
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Role of referral to secondary care
Number of subjects: 22
Study: 17881145

Group type: EXPERIMENTAL
Intervention: RT + short-course hormone therapy (STH)
Number of subjects: 2922

Group type: EXPERIMENTAL
Intervention: RT + long-term hormone therapy (LTH)
Number of subjects: 2922

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 2922
Study: 15954049

Group type: EXPERIMENTAL
Intervention: Exercise plus short‐duration passive stretch
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Exercise plus long‐duration passive stretch
Number of subjects: 150

Group type: COMPARATOR
Intervention: Exercise only
Number of subjects: 150
Study: 14502032

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10713298

Group type: EXPERIMENTAL
Intervention: Cycling at 60% VO(2peak) following caffeine consumption
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cycling at 60% VO(2peak) following placebo consumption
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Quiet rest following caffeine consumption
Number of subjects: 8

Group type: COMPARATOR
Intervention: Quiet rest following placebo consumption
Number of subjects: 8
Study: 8666769

Group type: EXPERIMENTAL
Intervention: Swan-Gantz catheter inserted without skin contact
Number of subjects: 33

Group type: COMPARATOR
Intervention: Single-lumen catheters with skin contact
Number of subjects: 33

Group type: COMPARATOR
Intervention: Swan-Gantz sheets
Number of subjects: 33
Study: 2000777

Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 0
Study: 6140229

Group type: EXPERIMENTAL
Intervention: 80 mg propranolol (Inderal)
Number of subjects: 15
Study: 31438901

Group type: EXPERIMENTAL
Intervention: Strategy A - Directly to families
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strategy B - To teaching staff only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strategy C - To health service staff only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0